Barbara Thompson, BS, PhD

TitleAssistant Professor
InstitutionUniversity of Southern California
DepartmentOccupational Science and Occupational Therapy
AddressCHP 133
Health Sciences Campus
Los Angeles CA 90089-9003
Phone+1 323 442 2808
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Barbara Thompson was most recently a research assistant professor at the Keck School of Medicine of USC, Department of Cell and Neurobiology. She had previously been a postdoctoral fellow at Vanderbilt University Medical Center's Department of Pharmacology. Dr. Thompson has conducted groundbreaking research in the neurobiology of developmental disorders and is contributing to the development of translational science in areas such as autism by developing and testing conceptual models which link clinical problems in human populations to animal studies in the neurosciences. Dr. Thompson has already demonstrated particular skill in interdisciplinary research collaborations and strengthens the Division’s critical mass in autism and sensory integration with a special focus on neuroscience research.

    Collapse Research 
    Collapse Research Activities and Funding
    Developmental consequences of in utero cocaine
    NIH/NIDA F32DA020981Mar 1, 2006 - Feb 28, 2009
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Thompson B, Levitt P. Complete or partial reduction of the Met receptor tyrosine kinase in distinct circuits differentially impacts mouse behavior. J Neurodev Disord. 2015; 7:35. PMID: 26523156; PMCID: PMC4628780.
    2. Howrey BT, Thompson B, Borkan J, Kennedy LB, Hughes LS, Johnson BH, Likumahuwa S, Westfall JM, Davis A, deGruy F. Partnering With Patients, Families, and Communities. Fam Med. 2015 Sep; 47(8):604-11. PMID: 26382118.
      View in: PubMed
    3. Hiller LT, Takata S, Thompson B. Conditioned place preference successfully established in typically developing children. Front Behav Neurosci. 2015; 9:187. PMID: 26257617; PMCID: PMC4507053.
    4. Eagleson KL, Campbell DB, Thompson B, Bergman MY, Levitt P. The autism risk genes MET and PLAUR differentially impact cortical development. Autism Res. 2011 Feb; 4(1):68-83. PMID: 21328570; PMCID: PMC3644181.
    5. Thompson B, Levitt P. The clinical-basic interface in defining pathogenesis in disorders of neurodevelopmental origin. Neuron. 2010 Sep 09; 67(5):702-12. PMID: 20826303; PMCID: PMC2940830.
    6. Thompson B, Levitt P. Now you see it, now you don't--closing in on allostasis and developmental basis of psychiatric disorders. Neuron. 2010 Feb 25; 65(4):437-9. PMID: 20188647.
      View in: PubMed
    7. Thompson B, Stanwood GD, Levitt P. Specificity of prenatal cocaine exposure effects on cortical interneurons is independent from dopamine D1 receptor co-localization. J Chem Neuroanat. 2010 Jul; 39(4):228-34. PMID: 20080176; PMCID: PMC2850967.
    8. Thompson B, Levitt P, Stanwood GD. Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci. 2009 Apr; 10(4):303-12. PMID: 19277053; PMCID: PMC2777887.
    9. Nash LR, Olson MM, Caskey JW, Thompson B. Outcomes of a Texas family medicine residency rural training track: 2000 through 2007. Tex Med. 2008 Sep; 104(9):59-63. PMID: 18834084.
      View in: PubMed
    10. Thompson B, Stanwood GD. Pleiotropic effects of neurotransmission during development: modulators of modularity. J Autism Dev Disord. 2009 Feb; 39(2):260-8. PMID: 18648918; PMCID: PMC2777884.
    11. Parlaman JP, Thompson B, Levitt P, Stanwood GD. Pharmacokinetic profile of cocaine following intravenous administration in the female rabbit. Eur J Pharmacol. 2007 Jun 01; 563(1-3):124-9. PMID: 17383635; PMCID: PMC1945095.
    12. Newton WP, Thompson B, Campbell TL, Spencer D. Keeping our eye on the ball: managing the evolution of Electronic Health Records. Ann Fam Med. 2006 Mar-Apr; 4(2):184-5. PMID: 16569725; PMCID: PMC1467010.
    13. Thompson B, Levitt P, Stanwood GD. Prenatal cocaine exposure specifically alters spontaneous alternation behavior. Behav Brain Res. 2005 Oct 14; 164(1):107-16. PMID: 16054247.
      View in: PubMed
    14. Thompson B, Rosen JB. Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs. Neuropharmacology. 2006 Jan; 50(1):57-68. PMID: 16185722.
      View in: PubMed
    15. Rosen JB, Adamec RE, Thompson B. Expression of egr-1 (zif268) mRNA in select fear-related brain regions following exposure to a predator. Behav Brain Res. 2005 Jul 30; 162(2):279-88. PMID: 15970222.
      View in: PubMed
    16. Thompson B, Erickson K, Schulkin J, Rosen JB. Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala. Behav Brain Res. 2004 Mar 02; 149(2):209-15. PMID: 15129783.
      View in: PubMed
    17. Schulkin J, Thompson B, Rosen JB. Demythologizing the emotions: adaptation, cognition, and visceral representations of emotion in the nervous system. Brain Cogn. 2003 Jun; 52(1):15-23. PMID: 12812800.
      View in: PubMed
    Barbara's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.